Furthermore, MYCN overexpression profoundly perturbs critical molecular pathways and the retinal cellular microenvironment, promoting tumor initiation and progression—particularly in RB1-proficient retinoblastoma. This evidence concerns the gene RB1 and retinoblastoma.